Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2003-02-24 (23 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LAGNY-SUR-MARNE (77400), Seine-et-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DES HAUTS DE LAGNY : revenue, balance sheet and financial ratios
SELARL PHARMACIE DES HAUTS DE LAGNY is a French company
founded 23 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LAGNY-SUR-MARNE (77400),
this company of category PME
shows in 2022 a revenue of 1.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DES HAUTS DE LAGNY (SIREN 447505546)
Indicator
2024
2023
2022
2021
2020
2019
2016
Revenue
N/C
N/C
1 832 709 €
N/C
N/C
N/C
N/C
Net income
35 439 €
35 620 €
187 618 €
133 172 €
78 103 €
100 193 €
163 890 €
EBITDA
N/C
N/C
250 611 €
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
10.2%
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SELARL PHARMACIE DES HAUTS DE LAGNY generates positive net income of 35 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 164 k€ -> 35 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
35 439 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 86%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
3.711%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
85.579%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DES HAUTS DE LAGNY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2019
2020
2021
2022
2023
2024
Debt ratio
82.631
29.534
22.976
16.859
11.109
7.621
3.711
Financial autonomy
45.392
68.446
72.146
73.72
78.774
82.282
85.579
Repayment capacity
None
None
None
None
0.942
None
None
Cash flow / Revenue
None%
None%
None%
None%
10.405%
None%
None%
Sector positioning
Debt ratio
3.712024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of SELARL PHARMACIE DES HAUT... (3.71) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
85.58%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+11 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE DES HAUT... (85.6%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.94 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of SELARL PHARMACIE DES HAUT... (0.94) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 192.02. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
192.021
Liquidity indicators evolution SELARL PHARMACIE DES HAUTS DE LAGNY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2019
2020
2021
2022
2023
2024
Liquidity ratio
113.859
114.165
118.646
143.146
195.453
199.122
192.021
Interest coverage
None
None
None
None
0.919
None
None
Sector positioning
Liquidity ratio
192.022024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good
In 2024, the liquidity ratio of SELARL PHARMACIE DES HAUT... (192.02) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.92x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of SELARL PHARMACIE DES HAUT... (0.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DES HAUTS DE LAGNY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
76 186 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
16
0
0
Customer payment term (days)
0
0
0
0
2
0
0
Supplier payment term (days)
0
0
0
0
42
0
0
Positioning of SELARL PHARMACIE DES HAUTS DE LAGNY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE DES HAUTS DE LAGNY is estimated at
494 754 €
(range 344 539€ - 740 181€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
344k€494k€740k€
494 754 €Range: 344 539€ - 740 181€
NAF 5 année 2024
Valuation method used
Net Income Multiple
35 439 €
×
14.0x
=494 755 €
Range: 344 539€ - 740 181€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DES HAUTS DE LAGNY with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DES HAUTS DE LAGNY
What is the revenue of SELARL PHARMACIE DES HAUTS DE LAGNY ?
The revenue of SELARL PHARMACIE DES HAUTS DE LAGNY in 2022 is 1.8 M€.
Is SELARL PHARMACIE DES HAUTS DE LAGNY profitable?
Yes, SELARL PHARMACIE DES HAUTS DE LAGNY generated a net profit of 35 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE DES HAUTS DE LAGNY ?
The headquarters of SELARL PHARMACIE DES HAUTS DE LAGNY is located in LAGNY-SUR-MARNE (77400), in the department Seine-et-Marne.
Where to find the tax return of SELARL PHARMACIE DES HAUTS DE LAGNY ?
The tax return of SELARL PHARMACIE DES HAUTS DE LAGNY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DES HAUTS DE LAGNY operate?
SELARL PHARMACIE DES HAUTS DE LAGNY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart